Strategic expansion M42 is expanding internationally with a Brazil footprint and clinic acquisitions, signaling a readiness to partner on cross-border healthcare delivery, telemedicine platforms, and export of Abu Dhabi medical expertise.

Tech powered care With a tech-driven approach, genomics and AI focus, there are sales opportunities for AI analytics platforms, cloud infrastructure, data security, and advanced medical devices that integrate with Azure Monitor, Kubernetes, and ISO certifications.

Public sector tie Active partnerships with Abu Dhabi Health initiatives and the UAE Ministry of Defense position M42 for government-related healthcare programs, research collaborations, and large-scale health IT deployments.

Stem cell potential Strategic collaboration with Abu Dhabi Biobank and Human Life CORD Japan indicates demand for cord-derived stem cell therapies, GMP facilities, and localised clinical trials, offering opportunities for suppliers and contract research services.

Educational platforms AI-powered patient education platform launches present a path to upsell digital health education tools, patient engagement solutions, remote monitoring, and subscription-based services for chronic disease management (e.g., kidney health).